Skip to main content
OpenTrials

Clinical trial condition

Immunoglobulin Light-chain Amyloidosis

Explore clinical trials studying Immunoglobulin Light-chain Amyloidosis. Study availability and eligibility vary by location and protocol.

187 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Immunoglobulin Light-chain Amyloidosis trial results

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

NCT04512235

Conditions
AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +13 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site San Francisco, California, United States
View all 110 locations
View Trial Details
Active, not recruiting

A Study of AT-02 in Subjects With Systemic Amyloidosis.

NCT05951049

Conditions
Amyloidosis, Amyloidosis; Systemic, Immune System Diseases, +10 more
Locations
  • Kansas City Kansas City, Kansas, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • OHSU (Oregon Health & Science University) Portland, Oregon, United States
  • Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

NCT04270175

Conditions
AL Amyloidosis, Alzheimer Disease, Amyloid, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Boston University Medical Center Boston, Massachusetts, United States
  • Weill Cornell Medicine - Multiple Myeloma Center New York, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Active, not recruiting

Ixazomib Maintenance Study in Patients With AL Amyloidosis

NCT03618537

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Completed

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

NCT05184088

Conditions
AL Amyloidosis, ATTR Amyloidosis, Amyloid Neuropathies, +23 more
Locations
  • St Luke's Hospital Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • University of Augsburg Augsburg, Germany
View all 14 locations
View Trial Details
Completed

A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

NCT04617925

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Centre hospitalier Universitaire de Limoges - Limoges, France
  • University Hospital Heidelberg Heidelberg, Germany
  • General Hospital of Athens "Alexandra" Athens, Greece
  • Fondazione I.R.C.C.S Policlinico "San Matteo" Pavia, Italy
View Trial Details

Related conditions